Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,053
Total Claims
$2.2M
Drug Cost
318
Beneficiaries
$7,068
Cost/Patient
Risk Score Breakdown 22/100
Score components are additive. Read full methodology
Peer Comparison vs. 21,141 Psychiatry providers
+317%
Cost per patient vs peers
$7,068 vs $1,696 avg
+61%
Brand preference vs peers
8.0% vs 5.0% avg
Brand vs Generic
Brand: 722 claims · $2.0M
Generic: 8,331 claims · $265K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Paliperidone Palmitate | 273 | $752K |
| Aripiprazole Lauroxil | 98 | $341K |
| Valbenazine Tosylate | 36 | $296K |
| Paliperidone Palmitate | 26 | $188K |
| Aripiprazole | 58 | $141K |
| Cariprazine Hcl | 102 | $133K |
| Olanzapine/Samidorphan Malate | 48 | $73K |
| Paliperidone | 107 | $36K |
| Lurasidone Hcl | 11 | $19K |
| Hydroxyzine Hcl | 816 | $14K |
| Ziprasidone Hcl | 191 | $13K |
| Quetiapine Fumarate | 841 | $13K |
| Duloxetine Hcl | 372 | $13K |
| Aripiprazole | 243 | $12K |
| Lurasidone Hcl | 42 | $11K |
Prescribing Profile
53
Unique Drugs
22.0
Anomaly Score
Patient Profile
55
Avg Age
62%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About